Abstract:The study of naturally circulating drug metabolites has been a focus of interest, since these metabolites may have different therapeutic and toxicological effects compared to the parent drug. The synthesis of metabolites outside of the human body is vital in order to conduct studies into the pharmacological activities of drugs and bioactive compounds. Current synthesis methods require significant purification and separation efforts or do not provide sufficient quantities for use in pharmacology experiments. Thus, there is a need for simple methods yielding high conversions whilst bypassing the requirement for a separation. Here we have developed and optimised flow chemistry methods in glass microfluidic reactors utilising surface-immobilised enzymes for sulfonation (SULT1a1) and glucuronidation (UGT1a1). Conversion occurs in flow, the precursor and co-factor are pumped through the device, react with the immobilised enzymes and the product is then simply collected at the outlet with no separation from a complex biological matrix required. Conversion only occurred when both the correct co-factor and enzyme were present within the microfluidic system. Yields of 0.97 ± 0.26 μg were obtained from the conversion of resorufin into resorufin sulfate over 2 h with the SULT1a1 enzyme and 0.47 μg of resorufin glucuronide over 4 h for UGT1a1. This was demonstrated to be significantly more than static test tube reactions at 0.22 μg (SULT1a1) and 0.19 μg (UGT1a1) over 4 h. With scaling out and parallelising, useable quantities of hundreds of micrograms for use in pharmacology studies can be synthesised simply.

Efficient Drug Metabolism Strategy Based on Microsome - Mesoporous Organosilica Nanoreactors

Confining Nanohybrid of Cdte Quantum Dots and Cytochrome P450 2d6 in Macroporous Ordered Siliceous Foam for Drug Metabolism

Amphiphilic Mesoporous Foam-Stabilized Pickering Emulsions as Versatile Nanoreactors for In Vitro Drug Metabolism

Electrochemically Driven Drug Metabolism Via Cytochrome P450 2c9 Isozyme Microsomes With Cytochrome P450 Reductase And Indium Tin Oxide Nanoparticle Composites

Photochemical Bionanoreactor for Efficient Visible-Light-Driven in Vitro Drug Metabolism.

Polydopamine Functionalized Nanoporous Graphene Foam As Nanoreactor for Efficient Electrode-Driven Metabolism of Steroid Hormones.

A Biomimetic Plasmonic Nanoreactor for Reliable Metabolite Detection

Electrochemically-Driven and Dynamic Enhancement of Drug Metabolism Via Cytochrome P450 Microsomes on Colloidal Gold/Graphene Nanocomposites

Water-in-oil microcompartments for the study of biomimetic drug metabolism

The Fe‐N‐C Nanozyme with Both Accelerated and Inhibited Biocatalytic Activities Capable of Accessing Drug–Drug Interactions

Fast Steroid Hormone Metabolism Assays with Electrochemical Liver Microsomal Bioreactor Based on Polydopamine Encapsulated Gold-Graphene Nanocomposite

Enhanced Metabolic Activity of Cytochrome P450 Via Carbon Nanocage-Based Photochemical Bionanoreactor.

Immobilised-enzyme microreactors for the identification and synthesis of conjugated drug metabolites

Towards Efficient Chemical Synthesis Via Engineering Enzyme Catalysis in Biomimetic Nanoreactors

Multi-compartmental MOF Microreactors Derived from Pickering Double Emulsions for Chemo-Enzymatic Cascade Catalysis

A General Strategy for Site-Directed Enzyme Immobilization by Using NiO Nanoparticle Decorated Mesoporous Silica.

Imitation of drug metabolism in human liver and cytotoxicity assay using a microfluidic device coupled to mass spectrometric detection.

Efficient Design Strategies for Nanozymes

Effective Control of Enzyme Activity Based on a Subtle Nanoreactor: A Promising Strategy for Biomedical Applications in the Future

Periodic mesoporous organosilica as a multifunctional nanodevice for large-scale characterization of membrane proteins.

Improving the Stability of Membrane-Binding Enzymes for the Sustainable Production of Monoterpenes in a MOF-on-aMOF Bifunctional Core-Shell Nanoreactor